secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001411690-26-000019
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics CEO Erik Holmlin terminated; Chairman Al Luderer named interim CEO
--------------------------------------------------------------------------------

- CEO Erik Holmlin terminated effective May 5, 2026; will serve as advisor under consulting agreement.
- Board appoints Chairman Albert Luderer as interim CEO and interim principal financial officer.
- Luderer receives $600k base salary, up to $400k bonus, and $4k/month housing/travel stipend.
- Chris Twomey appointed Lead Independent Director to support governance during transition.
- Company will immediately commence search for a permanent CEO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000141169026000019/0001411690-26-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000141169026000019/bngo-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001411690-26-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer